Comparison of Two Strategies of Glucocorticoid Withdrawal in Rheumatoid Arthritis Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Rheumatoid Arthritis
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Supportive Care
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
French multicenter double-blind controlled parallel-group randomized clinical trial Phase IV assessing whether a hydrocortisone replacement therapy could increase the success rate of GC withdrawal at one year, in patients with Rheumatoid Arthritis in low disease activity or remission, in comparison ...
French multicenter double-blind controlled parallel-group randomized clinical trial Phase IV assessing whether a hydrocortisone replacement therapy could increase the success rate of GC withdrawal at one year, in patients with Rheumatoid Arthritis in low disease activity or remission, in comparison to progressive decrease of GC (GC tapering).
Tracking Information
- NCT #
- NCT02997605
- Collaborators
- Not Provided
- Investigators
- Study Chair: Adeline RUYSSEN-WITRAND, MD, PhD University Hospital of Toulouse, Rheumatology Center Study Chair: Arnaud CONSTANTIN, MD, PhD University Hospital of Toulouse, Rheumatology Center
Get Well Soon